Is NCT02593851 results overdue?

Yes — results are overdue. Primary completion was 2017-03-21; the FDAAA-801 reporting deadline (2018-03-21) passed 3014 days ago and no results are posted on ClinicalTrials.gov.

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

NCT ID	NCT02593851 ↗
Sponsor	Janssen Sciences Ireland UC (INDUSTRY)
Phase	PHASE1
Status	TERMINATED
Primary completion	2017-03-21 (ACTUAL)
Reporting deadline	2018-03-21 (completion + 365d)
Days overdue	3014
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `110a69465b5632af…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02593851. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.